Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 156,062 | 272,677 | 28,395 |
| Marketable Securities | 8,174 | 9,942 | N/A |
| Receivables | 20,447 | 26,890 | 9,726 |
| Other current assets | 0 | -1 | 0 |
| TOTAL | $184,683 | $309,508 | $38,120 |
| Non-Current Assets | |||
| PPE Net | 2,885 | 950 | 1,677 |
| Investments And Advances | 6,405 | 13,929 | 12,336 |
| Intangibles | 27,080 | 27,082 | 26,367 |
| Other Non-Current Assets | 1,026 | 2,511 | 1,093 |
| TOTAL | $37,395 | $44,473 | $41,473 |
| Total Assets | $222,077 | $353,979 | $79,593 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 47,362 | 11,480 | 11,276 |
| Accounts payable and accrued liabilities | 47,422 | 51,107 | 16,305 |
| Accrued Expenses | 5,096 | 6,573 | 2,423 |
| Other current liabilities | 1,837 | 6,589 | 3,710 |
| TOTAL | $101,716 | $75,807 | $33,854 |
| Non-Current Liabilities | |||
| Long Term Debt | 31,442 | 2,774 | 9,616 |
| Deferred Revenues | N/A | 56 | 140 |
| Other Non-Current Liabilities | 45,002 | 63,255 | 28,549 |
| TOTAL | $76,444 | $66,029 | $38,166 |
| Total Liabilities | $178,161 | $141,835 | $72,019 |
| Shareholders' Equity | |||
| Common Shares | 685 | 681 | 235 |
| Retained earnings | -474,911 | -306,236 | -63,996 |
| Other shareholders' equity | -81 | 121 | -87,207 |
| TOTAL | $43,916 | $212,142 | $7,574 |
| Total Liabilities And Equity | $222,077 | $353,977 | $79,593 |